The long term forecast for ENZC is high REWARD with various risks along the way.
While the ITV-1 immunotherapy treatment in Africa is a step in the right direction, IMHO ENZC has BIGGER plans to be revealed sooner than later that led to the SPAC deal.
ENZC has been working tirelessly in the laboratory developing mAbs that is going to change the pharmaceutical industry like never before.
ENZC is on more solid footing today than they were 3 years ago.
We are guaranteed nothing however the sky is the limit with all the potential ENZC has.